Standard InChI: InChI=1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25)/t11-/m1/s1 (Source: PubChem)
IUPAC Name: (16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetrazatetracyclo[16.3.1.02,6.010,15]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile (Source: PubChem)
PubChem CID: 71731823 (Source: PubChem)
SMILES String: C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C (Source: PubChem)
Connectivity SMILES string: CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C (Source: PubChem)
Standard InChIKey: IIXWYSCJSQVBQM-LLVKDONJSA-N (Source: PubChem)
CAS Registry Number: 1454846-35-5 (Source: PubChem)
ChEBI ID: CHEBI:143117 (Source: PubChem)
ChEMBL ID: CHEMBL3286830 (Source: PubChem)
CompTox Dashboard Compound ID: DTXCID401513511 (Source: PubChem)
CompTox Dashboard Substance ID: DTXSID201027944 (Source: PubChem)
Wikidata ID: Q27285820 (Source: PubChem)
WHO ATC Classification Drug Code: L01ED05 (Source: ChEMBL)
WHO ATC Classification Drug Name: Lorlatinib (Source: ChEMBL)
Connectivity SMILES string: C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21 (Source: ChEMBL)
European Medicines Agency Name: Lorlatinib (Source: ChEMBL)
International Nonproprietary Name: Lorlatinib (Source: ChEMBL)
Merck Index Name: Lorlatinib (Source: ChEMBL)
Preferred Name: LORLATINIB (Source: ChEMBL)
Standard InChI: InChI=1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25)/t11-/m1/s1 (Source: ChEMBL)
Standard InChIKey: IIXWYSCJSQVBQM-LLVKDONJSA-N (Source: ChEMBL)
US Adopted Name: Lorlatinib (Source: ChEMBL)